Acromegaly at diagnosis in 3173 patients from the Liège Acromegaly Survey (LAS) Database

Local optometrists are a major source of referrals to a pituitary tumour clinic

(2017) H Surchi et al.   ENDOCRINE-RELATED CANCER

A multivariable prediction model for pegvisomant dosing: monotherapy and in combination with long-acting somatostatin analogues

(2017) S E Franck et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Changes in the management and comorbidities of acromegaly over three decades: the French Acromegaly Registry

(2017) Luigi Maione et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Complications of acromegaly: cardiovascular, respiratory and metabolic comorbidities

(2017) Rosario Pivonello et al.   Pituitary

T2-weighted MRI signal predicts hormone and tumor responses to somatostatin analogs in acromegaly

(2016) Iulia Potorac et al.   ENDOCRINE-RELATED CANCER

Comorbidities, treatment patterns and cost-of-illness of acromegaly in Sweden: a register-linkage population-based study

(2016) Eva Lesén et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Pituitary Medicine From Discovery to Patient-Focused Outcomes

(2016) Shlomo Melmed   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

The Mexican Acromegaly Registry: Clinical and Biochemical Characteristics at Diagnosis and Therapeutic Outcomes

(2016) Lesly A. Portocarrero-Ortiz et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Incidence and prevalence of acromegaly in a large US health plan database

(2016) Tanya Burton et al.   Pituitary

“Micromegaly”: an update on the prevalence of acromegaly with apparently normal GH secretion in the modern era

(2016) Laura B. Butz et al.   Pituitary

Epidemiology of acromegaly: review of population studies

(2016) Aikaterini Lavrentaki et al.   Pituitary

Long-Term Treatment with Pegvisomant as Monotherapy in Patients with Acromegaly: Experience from Acrostudy

(2015) Pamela Freda et al.   Endocrine Practice

Pituitary MRI characteristics in 297 acromegaly patients based on T2-weighted sequences

(2015) I. Potorac et al.   ENDOCRINE-RELATED CANCER

Mortality in acromegaly: a 20-year follow-up study

(2015) Elina Ritvonen et al.   ENDOCRINE-RELATED CANCER

Safety of long-term treatment with Pegvisomant: analysis of Spanish patients included in global ACROSTUDY

(2015) I. Bernabeu et al.   Pituitary

Effects of Long-term Growth Hormone Replacement in Adults With Growth Hormone Deficiency Following Cure of Acromegaly: A KIMS Analysis

(2014) Nicholas A. Tritos et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Acromegaly: An Endocrine Society Clinical Practice Guideline

(2014) Laurence Katznelson et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

The Liege Acromegaly Survey (LAS): A new software tool for the study of acromegaly

(2012) Patrick Petrossians et al.   ANNALES D ENDOCRINOLOGIE

Mortality and pituitary disease

(2012) Paul M. Stewart et al.   ANNALES D ENDOCRINOLOGIE

Long-Term Safety of Pegvisomant in Patients with Acromegaly: Comprehensive Review of 1288 Subjects in ACROSTUDY

(2012) A. J. van der Lely et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Changes in acromegaly treatment over four decades in Spain: analysis of the Spanish Acromegaly Registry (REA)

(2012) Gemma Sesmilo et al.   Pituitary

A consensus on the diagnosis and treatment of acromegaly complications

(2012) S. Melmed et al.   Pituitary

Polycythemia as rare secondary direct manifestation of acromegaly: management and single-centre epidemiological data

(2011) Gabriele Zoppoli et al.   Pituitary

Mortality in Patients with Pituitary Disease

(2010) Mark Sherlock et al.   ENDOCRINE REVIEWS

Endocrine Aspects of Obstructive Sleep Apnea

(2010) Pierre Attal et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Clinical Characteristics and Therapeutic Responses in Patients with Germ-LineAIPMutations and Pituitary Adenomas: An International Collaborative Study

(2010) Adrian F. Daly et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

A Consensus on Criteria for Cure of Acromegaly

(2010) A. Giustina et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Monitoring disease activity using GH and IGF-I in the follow-up of 501 patients with acromegaly

(2009) M. Sherlock et al.   CLINICAL ENDOCRINOLOGY

Features at diagnosis of 324 patients with acromegaly did not change from 1981 to 2006: acromegaly remains under-recognized and under-diagnosed

(2009) Tirissa J. Reid et al.   CLINICAL ENDOCRINOLOGY

Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK)

(2009) Alberto Fernandez et al.   CLINICAL ENDOCRINOLOGY

ACROSTUDY: the first 5 years

(2009) Peter J Trainer   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Tumor ZAC1 expression is associated with the response to somatostatin analog therapy in patients with acromegaly

(2009) Marily Theodoropoulou et al.   INTERNATIONAL JOURNAL OF CANCER

A meta-analysis of the effect of lowering serum levels of GH and IGF-I on mortality in acromegaly

(2008) I M Holdaway et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Divergence between Growth Hormone and Insulin-Like Growth Factor-I Concentrations in the Follow-Up of Acromegaly

(2008) Orsalia Alexopoulou et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Assessment of the Magnitude of Growth Hormone Hypersecretion in Active Acromegaly: Reliability of Different Sampling Models

(2007) Katica Bajuk Studen et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Mortality in Acromegaly: A Metaanalysis

(2007) O. M. Dekkers et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM